International Stem Cell (ISCO) Dividends Paid - Common (2012)
International Stem Cell (ISCO) posted quarterly Dividends Paid - Common of -$1.4 million for Q4 2012, down 24.43% quarter-over-quarter from -$1.1 million in Q3 2012.
International Stem Cell (ISCO) Dividends Paid - Common (2012) Analysis & Trends
International Stem Cell (ISCO) has reported Dividends Paid - Common for 1 consecutive years, with -$1.4 million the latest figure, recorded in Q4 2012.
- In Q4 2012, Dividends Paid - Common changed N/A year-over-year to -$1.4 million; the TTM figure through Sep 2013 stood at -$1.4 million (changed N/A YoY), while the FY2010 annual figure was -$524000.0, changed N/A from the prior year.
- Dividends Paid - Common declined to -$1.4 million in Q4 2012 per ISCO's latest filing, from -$1.1 million in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $1.1 million in Q2 2012 and bottomed at -$1.4 million in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.99 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 65.11 Bn | 59.92 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.73 Bn | 50.59 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | 34.60 Mn |
| 10 | International Stem Cell | 3.20 Mn | 2.11 Mn | 1.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | -1.38 Mn |
| Dec 31, 2012 | -1.38 Mn |
| Sep 30, 2012 | -1.11 Mn |
| Sep 30, 2012 | -1.11 Mn |
| Jun 30, 2012 | 1.11 Mn |
| Jun 30, 2012 | 1.11 Mn |